2022 Peer Review | Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors Read more
2023 Peer Review | Breakthrough Therapy Designation Criteria Identify Drugs that Improve Clinical Outcomes for Patients: A Case for More Streamlined Coverage of Promising Therapies Read more
2022 Peer Review | Abstract 1023: Evaluating the impact of the RACE act: An interim analysis Read more
2022 Peer Review | Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Read more
2021 Peer Review | Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England Read more
2021 Peer Review | The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies Read more
2021 Peer Review | Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot Read more
2021 Peer Review | Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project Read more
